Aspirin for treating depression, a randomized double blind controlled clinical trial
Phase 2
- Conditions
- Major Depressive disorder.Depressive episodeF30-?39
- Registration Number
- IRCT201306203930N27
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients with major depressive disorder according to DSM-VI, both gender, and aged between 17 and 70 years old. Exclusion criteria: receive NSAIDs concurrently, reported positive history of cancer, serious medical condition, and hypothyroidism.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hamilton Derepssion Rating Scale. Timepoint: baseline, 2 week, and 6 week. Method of measurement: Interveiwe.
- Secondary Outcome Measures
Name Time Method